Dopamine Transporter Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 2831 | Bupropion hydrochloride |
| Non-selective inhibitor of dopamine and noradrenalin transporters | |
| 4798 | (S)-Duloxetine hydrochloride |
| Potent 5-HT and NA reuptake inhibitor; also blocks dopamine reuptake | |
| 0513 | GBR 12783 dihydrochloride |
| Potent and selective DA uptake inhibitor | |
| 0421 | GBR 12909 dihydrochloride |
| Selective DA uptake inhibitor; also σ ligand | |
| 1588 | Indatraline hydrochloride |
| Potent dopamine uptake inhibitor; also inhibits 5-HT and noradrenalin uptake | |
| 4351 | JHW 007 hydrochloride |
| High affinity dopamine uptake inhibitor | |
| 1992 | Nomifensine |
| Potent noradrenalin and dopamine uptake inhibitor. Antidepressant | |
| 2742 | Reserpine |
| Inhibitor of vesicular monoamine transport | |
| 1497 | Rimcazole dihydrochloride |
| DAT inhibitor. Also σ2 antagonist | |
| 2175 | Tetrabenazine |
| Potent inhibitor of vesicular monoamine transport; depletes dopamine stores |
Dopamine Scientific Review
Our Dopamine receptors review gives an overview of the dopamine receptor subtypes, and the receptor agonists and antagonists used to study them.
Request copyRequest PDFAddiction Life Science Poster
Written by Prof David Nutt, this poster summarizes the brain circuits and neurotransmitter systems that are affected by the main classes of addictive drugs.
Request copyDownload PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDF